未知机构：连锁药房事件点评商务部等9部门关于促进药品零售行业高质量发展的意见东吴医药朱-20260123

Summary of the Conference Call on the Retail Pharmaceutical Industry Industry Overview - The conference call discusses the retail pharmaceutical industry in China, specifically focusing on the opinions issued by the Ministry of Commerce and nine other departments aimed at promoting high-quality development in the sector as of January 22, 2026 [1] Core Points and Arguments 1. Encouragement of Mergers and Acquisitions: The opinions encourage retail pharmaceutical companies to legally engage in horizontal mergers and acquisitions, allowing for the "transfer" of medical insurance qualifications. This aims to optimize the application process for medical insurance qualifications and allows existing qualifications to continue to be used. This will help resolve the transfer issues faced by small pharmacies and accelerate the acquisition pace of leading companies, thereby increasing industry concentration [2][3] 2. Equal Medical Insurance Treatment: Designated pharmacies will enjoy the same medical insurance treatment as grassroots medical institutions. Additionally, personal accounts from employee medical insurance can be used for purchasing medications for close relatives. Optimizing the medical insurance settlement process will shorten settlement times, which is expected to enhance customer traffic and sales for pharmacies [3] 3. Facilitation of Prescription Flow: The opinions encourage compliant physical medical institutions and internet hospitals to collaborate with retail pharmaceutical companies through electronic prescription transfer platforms. This could potentially resolve previous challenges in electronic prescription transfers and further promote the outflow of prescriptions [3] 4. Strengthening Regulation: There will be a continuous effort to unify online and offline regulation, with strict measures against violations by internet hospitals and the illegal practice of "online hanging certificates" by licensed physicians. This aims to reduce the phenomenon of "bad money driving out good," benefiting compliant offline pharmacies [3] 5. Establishment of Pharmaceutical Service Platforms: Retail pharmaceutical chain enterprises are allowed to establish their own pharmaceutical service platforms, where licensed pharmacists registered at the headquarters can conduct remote prescription reviews. This service can supplement the absence of pharmacists during non-working hours, eliminating the requirement for pharmacists to be present at the store, thereby reducing costs and risks of violations [3]